Role of the immune response in recovery from Sindbis virus encephalitis in mice.

PubWeight™: 2.32‹?› | Rank: Top 2%

🔗 View Article (PMID 845432)

Published in J Immunol on March 01, 1977

Authors

D E Griffin, R T Johnson

Articles citing this

The alphaviruses: gene expression, replication, and evolution. Microbiol Rev (1994) 16.68

Production of infectious RNA transcripts from Sindbis virus cDNA clones: mapping of lethal mutations, rescue of a temperature-sensitive marker, and in vitro mutagenesis to generate defined mutants. J Virol (1987) 9.24

Molecular basis of Sindbis virus neurovirulence in mice. J Virol (1988) 3.90

Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing). J Virol (1988) 3.84

Infectious Sindbis virus transient expression vectors for studying antigen processing and presentation. Proc Natl Acad Sci U S A (1992) 2.86

Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice. J Virol (1995) 2.70

Viral determinants of age-dependent virulence of Sindbis virus for mice. J Virol (1993) 1.95

Deduced consensus sequence of Sindbis virus strain AR339: mutations contained in laboratory strains which affect cell culture and in vivo phenotypes. J Virol (1996) 1.88

Neurovirulent strains of Alphavirus induce apoptosis in bcl-2-expressing cells: role of a single amino acid change in the E2 glycoprotein. Proc Natl Acad Sci U S A (1994) 1.84

Luciferase imaging of a neurotropic viral infection in intact animals. J Virol (2003) 1.83

PKR-dependent and -independent mechanisms are involved in translational shutoff during Sindbis virus infection. J Virol (2004) 1.81

Mechanism of altered Sindbis virus neurovirulence associated with a single-amino-acid change in the E2 Glycoprotein. J Virol (1991) 1.80

Sindbis virus mutations which coordinately affect glycoprotein processing, penetration, and virulence in mice. J Virol (1989) 1.75

Characterization of Ross River virus tropism and virus-induced inflammation in a mouse model of viral arthritis and myositis. J Virol (2006) 1.73

Alphavirus neurovirulence: monoclonal antibodies discriminating wild-type from neuroadapted Sindbis virus. J Virol (1985) 1.64

Identification of adult mouse neurovirulence determinants of the Sindbis virus strain AR86. J Virol (2005) 1.53

Monoclonal antibody cure and prophylaxis of lethal Sindbis virus encephalitis in mice. J Virol (1986) 1.43

Attenuation of Sindbis virus neurovirulence by using defined mutations in nontranslated regions of the genome RNA. J Virol (1992) 1.34

The role of CD8(+) T cells and major histocompatibility complex class I expression in the central nervous system of mice infected with neurovirulent Sindbis virus. J Virol (2000) 1.34

Differences between C57BL/6 and BALB/cBy mice in mortality and virus replication after intranasal infection with neuroadapted Sindbis virus. J Virol (2000) 1.30

Sindbis virus entry into cells triggers apoptosis by activating sphingomyelinase, leading to the release of ceramide. J Virol (2000) 1.29

Molecular analysis of neurovirulent strains of Sindbis virus that evolve during persistent infection of scid mice. J Virol (1993) 1.28

A single amino acid change in nsP1 attenuates neurovirulence of the Sindbis-group alphavirus S.A.AR86. J Virol (2000) 1.27

Inhibition of nitric oxide synthesis increases mortality in Sindbis virus encephalitis. J Virol (1996) 1.25

Heparan sulfate binding can contribute to the neurovirulence of neuroadapted and nonneuroadapted Sindbis viruses. J Virol (2007) 1.24

Synergistic roles of antibody and interferon in noncytolytic clearance of Sindbis virus from different regions of the central nervous system. J Virol (2007) 1.21

Induction of apoptosis by Sindbis virus occurs at cell entry and does not require virus replication. J Virol (1999) 1.19

Protection from fatal viral encephalomyelitis: AMPA receptor antagonists have a direct effect on the inflammatory response to infection. Proc Natl Acad Sci U S A (2008) 1.15

Activation of divergent neuronal cell death pathways in different target cell populations during neuroadapted sindbis virus infection of mice. J Virol (2000) 1.10

Noncytolytic clearance of sindbis virus infection from neurons by gamma interferon is dependent on Jak/STAT signaling. J Virol (2009) 1.09

A single mutation in the E2 glycoprotein important for neurovirulence influences binding of sindbis virus to neuroblastoma cells. J Virol (2002) 1.07

Recovery from viral encephalomyelitis: immune-mediated noncytolytic virus clearance from neurons. Immunol Res (2010) 1.06

A single amino acid change in the E2 glycoprotein of Sindbis virus confers neurovirulence by altering an early step of virus replication. J Virol (1997) 1.03

Genetic determinants of Sindbis virus neuroinvasiveness. J Virol (1997) 1.01

Interleukin 10 modulation of pathogenic Th17 cells during fatal alphavirus encephalomyelitis. Proc Natl Acad Sci U S A (2014) 1.00

Characterization of a Chinese hamster ovary cell line developed by retroviral insertional mutagenesis that is resistant to Sindbis virus infection. J Virol (1999) 1.00

Role of antibody response in recovery from K-papovavirus infection in mice. Infect Immun (1980) 0.98

Genetic control of neuroadapted sindbis virus replication in female mice maps to chromosome 2 and associates with paralysis and mortality. J Virol (2001) 0.89

Interactions between immune cells and antibody in protection from fatal Sindbis virus encephalitis. Infect Immun (1979) 0.88

Mutations in nsP1 and PE2 are critical determinants of Ross River virus-induced musculoskeletal inflammatory disease in a mouse model. Virology (2010) 0.87

Intravenous inoculation of a bat-associated rabies virus causes lethal encephalopathy in mice through invasion of the brain via neurosecretory hypothalamic fibers. PLoS Pathog (2009) 0.85

Immunization with nonstructural proteins promotes functional recovery of alphavirus-infected neurons. J Virol (1997) 0.83

Postinfection therapy of arbovirus infections in mice. Antimicrob Agents Chemother (1989) 0.82

Distinct Immune Responses in Resistant and Susceptible Strains of Mice during Neurovirulent Alphavirus Encephalomyelitis. J Virol (2015) 0.80

Mice deficient in interferon-gamma or interferon-gamma receptor 1 have distinct inflammatory responses to acute viral encephalomyelitis. PLoS One (2013) 0.78

Studies of immune responses during recovery from Sindbis virus encephalitis in selectively reconstituted, thymectomized, lethally irradiated mice. Infect Immun (1981) 0.77

Protective Effects of Glutamine Antagonist 6-Diazo-5-Oxo-l-Norleucine in Mice with Alphavirus Encephalomyelitis. J Virol (2016) 0.75

Alphavirus Encephalomyelitis: Mechanisms and Approaches to Prevention of Neuronal Damage. Neurotherapeutics (2016) 0.75

Articles by these authors

Mammalian cell fusion: studies on the regulation of DNA synthesis and mitosis. Nature (1970) 5.90

Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. Nature (1993) 4.81

The neurological manifestations of systemic lupus erythematosus. Medicine (Baltimore) (1968) 4.40

Mammalian cell fusion: induction of premature chromosome condensation in interphase nuclei. Nature (1970) 4.21

Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen. Cancer Res (2001) 4.12

Molecular basis of Sindbis virus neurovirulence in mice. J Virol (1988) 3.90

Antibody-mediated clearance of alphavirus infection from neurons. Science (1991) 3.70

Mechanism of suppression of cell-mediated immunity by measles virus. Science (1996) 3.55

A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. Cancer Res (2001) 3.37

Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler (2008) 3.28

Antigenic shift of visna virus in persistently infected sheep. Science (1977) 3.17

Isolation of virus related to SV40 from patients with progressive multifocal leukoencephalopathy. N Engl J Med (1972) 3.09

Slow virus replication: the role of macrophages in the persistence and expression of visna viruses of sheep and goats. J Gen Virol (1982) 2.87

Binding of Sindbis virus to cell surface heparan sulfate. J Virol (1998) 2.82

Characterization of Shigella dysenteriae 1 (Shiga) toxin purified by anti-Shiga toxin affinity chromatography. Infect Immun (1980) 2.82

Selection of a fixative for identifying T cell subsets, B cells, and macrophages in paraffin-embedded mouse spleen. J Immunol Methods (1983) 2.82

Alphavirus-induced apoptosis in mouse brains correlates with neurovirulence. J Virol (1996) 2.65

Age-dependent resistance to viral encephalitis: studies of infections due to Sindbis virus in mice. J Infect Dis (1972) 2.56

Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol (1992) 2.52

Activation of caprine arthritis-encephalitis virus expression during maturation of monocytes to macrophages. Infect Immun (1983) 2.52

Pathogenesis of viral infections of the nervous system. N Engl J Med (1968) 2.48

Modulation of cell death by Bcl-XL through caspase interaction. Proc Natl Acad Sci U S A (1998) 2.42

A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells/. Nature (1994) 2.35

Bc1-2 protects mice against fatal alphavirus encephalitis. Proc Natl Acad Sci U S A (1996) 2.31

Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice. N Engl J Med (1977) 2.23

Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann Neurol (1996) 2.22

Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J Virol (1994) 2.21

Purification and biological characterization of shiga toxin from Shigella dysenteriae 1. Infect Immun (1982) 2.21

Infection of monocytes during measles. J Infect Dis (1993) 2.14

Complementation analysis on virus-fused Chinese hamster cells with nutritional markers. Science (1969) 2.12

Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann Neurol (1993) 2.09

Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann Neurol (1998) 2.05

Basis of neurovirulence in Sindbis virus encephalomyelitis of mice. Lab Invest (1988) 2.05

Apoptosis as a cause of death in measles virus-infected cells. J Virol (1995) 1.97

Interferon-gamma-mediated site-specific clearance of alphavirus from CNS neurons. Science (2001) 1.95

Viral determinants of age-dependent virulence of Sindbis virus for mice. J Virol (1993) 1.95

Etiology of progressive multifocal leukoencephalopathy. Identification of papovavirus. N Engl J Med (1973) 1.90

Role of the immune response in age-dependent resistance of mice to encephalitis due to Sindbis virus. J Infect Dis (1976) 1.86

Successful DNA immunization against measles: neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles. Nat Med (2000) 1.85

Use of a new CD4-positive HeLa cell clone for direct quantitation of infectious human immunodeficiency virus from blood cells of AIDS patients. J Infect Dis (1991) 1.85

Viral infections and demyelinating diseases. N Engl J Med (1973) 1.84

Neurovirulent strains of Alphavirus induce apoptosis in bcl-2-expressing cells: role of a single amino acid change in the E2 glycoprotein. Proc Natl Acad Sci U S A (1994) 1.84

Virus mutation during 'slow infection': temporal development and characterization of mutants of visna virus recovered from sheep. J Gen Virol (1978) 1.80

Mechanism of altered Sindbis virus neurovirulence associated with a single-amino-acid change in the E2 Glycoprotein. J Virol (1991) 1.80

Slow virus infection: replication and mechanisms of persistence of visna virus in sheep. J Infect Dis (1977) 1.78

Identification of a putative alphavirus receptor on mouse neural cells. J Virol (1991) 1.78

Hydrocephalus following viral infection: the pathology of aqueductal stenosis developing after experimental mumps virus infection. J Neuropathol Exp Neurol (1968) 1.75

Abnormal T-cell subset proportions in vitamin-A-deficient children. Lancet (1993) 1.75

Japanese encephalitis: immunocytochemical studies of viral antigen and inflammatory cells in fatal cases. Ann Neurol (1985) 1.73

Experimental rabies. Studies of cellular vulnerability and pathogenesis using fluorescent antibody staining. J Neuropathol Exp Neurol (1965) 1.72

In vitro evidence for a dual role of tumor necrosis factor-alpha in human immunodeficiency virus type 1 encephalopathy. Ann Neurol (1995) 1.70

Large-plaque mutants of Sindbis virus show reduced binding to heparan sulfate, heightened viremia, and slower clearance from the circulation. J Virol (2000) 1.69

Hydrocephalus as a sequela of experimental myxovirus infections. Exp Mol Pathol (1969) 1.68

Pathogenesis of human poliovirus infection in mice. I. Clinical and pathological studies. J Neuropathol Exp Neurol (1980) 1.68

A postprophase topoisomerase II-dependent chromatid core separation step in the formation of metaphase chromosomes. J Cell Biol (1995) 1.65

Alphavirus neurovirulence: monoclonal antibodies discriminating wild-type from neuroadapted Sindbis virus. J Virol (1985) 1.64

The pathogenesis of spinal cord involvement in the encephalomyelitis of mice caused by neuroadapted Sindbis virus infection. Lab Invest (1987) 1.63

Recombinant measles viruses with mutations in the C, V, or F gene have altered growth phenotypes in vivo. J Virol (1998) 1.62

Measles virus infection in rhesus macaques: altered immune responses and comparison of the virulence of six different virus strains. J Infect Dis (1999) 1.62

Measles virus infection of thymic epithelium in the SCID-hu mouse leads to thymocyte apoptosis. J Virol (1996) 1.61

Nucleo-cytoplasmic interactions in the acheivement of nuclear synchrony in DNA synthesis and mitosis in multinucleate cells. Biol Rev Camb Philos Soc (1971) 1.61

A double labeling technique for performing immunocytochemistry and in situ hybridization in virus infected cell cultures and tissues. J Virol Methods (1985) 1.60

Acute measles in patients with and without neurological involvement: distribution of measles virus antigen and RNA. J Infect Dis (1988) 1.59

Cytokine expression of macrophages in HIV-1-associated vacuolar myelopathy. Neurology (1993) 1.59

Profile of Escherichia coli O157:H7 pathogen responsible for hamburger-borne outbreak of hemorrhagic colitis and hemolytic uremic syndrome in Washington. J Clin Microbiol (1993) 1.58

Physiological characterization of heat-defective (temperature-sensitive) poliovirus mutants: preliminary classification. Virology (1966) 1.56

Biological characterization of the virus causing leukoencephalitis and arthritis in goats. J Gen Virol (1980) 1.53

Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients. J Virol (1998) 1.52

Age dependence of viral expression: comparative pathogenesis of two rodent-adapted strains of measles virus in mice. Infect Immun (1974) 1.51

Persistence of viral RNA in mouse brains after recovery from acute alphavirus encephalitis. J Virol (1992) 1.51

Measles encephalomyelitis--clinical and immunologic studies. N Engl J Med (1984) 1.50

Spongiform polioencephalomyelopathy caused by a murine retrovirus. I. Pathogenesis of infection in newborn mice. Lab Invest (1980) 1.48

Efficiency of in situ hybridization as a function of probe size and fixation technique. J Virol Methods (1985) 1.47

Camptothecin cytotoxicity in mammalian cells is associated with the induction of persistent double strand breaks in replicating DNA. Nucleic Acids Res (1991) 1.47

Low pH-dependent Sindbis virus-induced fusion of BHK cells: differences between strains correlate with amino acid changes in the E1 glycoprotein. Virology (1989) 1.46

Long term intraparenchymal Ig secretion after acute viral encephalitis in mice. J Immunol (1992) 1.45

Release of Shiga toxin from Shigella dysenteriae 1 by polymyxin B. Infect Immun (1983) 1.43

Papovavirus of JC type in progressive multifocal leukoencephalopathy. Rapid identification and subsequent isolation. Arch Neurol (1973) 1.43

Monoclonal antibody cure and prophylaxis of lethal Sindbis virus encephalitis in mice. J Virol (1986) 1.43

Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia. Ann Neurol (1999) 1.42

Specificity of the inflammatory response in viral encephalitis. I. Adoptive immunization of immunosuppressed mice infected with Sindbis virus. J Exp Med (1972) 1.39

Mouse hepatitis virus-induced recurrent demyelination. A preliminary report. Arch Neurol (1975) 1.39

The effect of complement depletion on the course of Sindbis virus infection in mice. J Immunol (1978) 1.38

Topoisomerase II inhibition prevents anaphase chromatid segregation in mammalian cells independently of the generation of DNA strand breaks. J Cell Sci (1993) 1.38

Changes in cytokine production after measles virus vaccination: predominant production of IL-4 suggests induction of a Th2 response. Clin Immunol Immunopathol (1993) 1.38

Pathogenesis of encephalitis induced in newborn mice by virulent and avirulent strains of Sindbis virus. J Virol (1990) 1.38

The pathogenesis of acute viral encephalitis and postinfectious encephalomyelitis. J Infect Dis (1987) 1.37

Early immune responses in visna, a slow viral disease of sheep. J Infect Dis (1978) 1.37

Pathogenesis of human poliovirus infection in mice. II. Age-dependency of paralysis. J Neuropathol Exp Neurol (1980) 1.37

Regulation of lymphocyte homing into the brain during viral encephalitis at various stages of infection. J Immunol (1996) 1.36

An explanation for the localization of herpes simplex encephalitis? Ann Neurol (1979) 1.35

Production of atypical measles in rhesus macaques: evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion-inhibiting antibody. Nat Med (1999) 1.35

Mammalian cell fusion. 3. A HeLa cell inducer of premature chromosome condensation active in cells from a variety of animal species. J Cell Physiol (1970) 1.34